579 related articles for article (PubMed ID: 37334366)
1. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
2. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
3. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
[TBL] [Abstract][Full Text] [Related]
4. Cancer organoid co-culture model system: Novel approach to guide precision medicine.
Yuan J; Li X; Yu S
Front Immunol; 2022; 13():1061388. PubMed ID: 36713421
[TBL] [Abstract][Full Text] [Related]
5. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
6. Tumor Organoids: The Era of Personalized Medicine.
Rassomakhina NV; Ryazanova AY; Likhov AR; Bruskin SA; Maloshenok LG; Zherdeva VV
Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S127-S147. PubMed ID: 38621748
[TBL] [Abstract][Full Text] [Related]
7. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
8. Organoids: approaches and utility in cancer research.
Zhou B; Feng Z; Xu J; Xie J
Chin Med J (Engl); 2023 Aug; 136(15):1783-1793. PubMed ID: 37365679
[TBL] [Abstract][Full Text] [Related]
9. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
10. Progress in patient-derived liver cancer cell models: a step forward for precision medicine.
Zhang Z; Hui L
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1707-1717. PubMed ID: 37766458
[TBL] [Abstract][Full Text] [Related]
11. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
[TBL] [Abstract][Full Text] [Related]
12. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
13. Converging bioprinting and organoids to better recapitulate the tumor microenvironment.
Wang X; Luo Y; Ma Y; Wang P; Yao R
Trends Biotechnol; 2024 May; 42(5):648-663. PubMed ID: 38071145
[TBL] [Abstract][Full Text] [Related]
14. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
Ren X; Chen W; Yang Q; Li X; Xu L
J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
[TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived organoids as a model for tumor research.
Wang J; Feng X; Li Z; Chen Y; Huang W
Prog Mol Biol Transl Sci; 2022; 189(1):259-326. PubMed ID: 35595351
[TBL] [Abstract][Full Text] [Related]
18. Reconstructing the tumor architecture into organoids.
Luo Z; Zhou X; Mandal K; He N; Wennerberg W; Qu M; Jiang X; Sun W; Khademhosseini A
Adv Drug Deliv Rev; 2021 Sep; 176():113839. PubMed ID: 34153370
[TBL] [Abstract][Full Text] [Related]
19. Emerging organoid models: leaping forward in cancer research.
Fan H; Demirci U; Chen P
J Hematol Oncol; 2019 Dec; 12(1):142. PubMed ID: 31884964
[TBL] [Abstract][Full Text] [Related]
20. Organoid technology and applications in cancer research.
Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
